Prerna Mewawalla

6PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersEconomic models and forecastingGene and molecular therapyCardiovascular medicine and haematology not elsewhere classifiedHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 26, 2026
Incidence and Associated Risk Factors in the Development of Carfilzomib-Induced Cardiovascular Toxicity.

|Jul 27, 2026
The ClinicalTrials.gov Landscape of Multiple Myeloma Clinical Trials: A 20-Year Analysis of Geographic Distribution and Growth Patterns: USMIRC Analysis.

|Jun 25, 2026
Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRC.

|May 26, 2026
High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis.

|May 26, 2026
Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients.

|Mar 27, 2026
Maintenance Strategies in High-Risk Myeloma: A Multicenter Comparison of Bortezomib-Lenalidomide Versus Lenalidomide Alone: A USMIRC Multicenter Analysis.

Sruthi P Ramanan, Oyepeju F Abioye, Shebli Atrash

Pageof 1

Frequent Collaborators

6 joint publications

Shebli Atrash

6 joint publications

Zahra Mahmoudjafari

6 joint publications

Al-Ola Abdallah

5 joint publications

Omar Alkharabsheh